Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Liquid biopsy from research to clinical practice: focus on non-small cell lung cancer
Umberto Malapelle, Pasquale Pisapia, Alfredo Addeo, et al.
Expert Review of Molecular Diagnostics (2021) Vol. 21, Iss. 11, pp. 1165-1178
Closed Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

The evolving role of liquid biopsy in lung cancer
Umberto Malapelle, Pasquale Pisapia, Francesco Pepe, et al.
Lung Cancer (2022) Vol. 172, pp. 53-64
Closed Access | Times Cited: 48
Critical Factors in the Analytical Work Flow of Circulating Tumor DNA-Based Molecular Profiling
Paul van der Leest, Ed Schuuring
Clinical Chemistry (2024) Vol. 70, Iss. 1, pp. 220-233
Open Access | Times Cited: 11
The Bridge: Supernatant Derived From Cytological Sample Preparations
Sinchita Roy‐Chowdhuri
Cytopathology (2025)
Closed Access | Times Cited: 1
Circulating biomarkers as predictors of response to immune checkpoint inhibitors in NSCLC: Are we on the right path?
Calogera Claudia Spagnolo, Francesco Pepe, Giuliana Ciappina, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 197, pp. 104332-104332
Open Access | Times Cited: 7
The role of liquid biopsy in epithelial ovarian cancer: State of the art
Luigi Della Corte, Gianluca Russo, Francesco Pepe, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 194, pp. 104263-104263
Closed Access | Times Cited: 6
Pan-immune-inflammation and its dynamics: predictors of survival and immune-related adverse events in patients with advanced NSCLC receiving immunotherapy
Yiqun Chen, Lingyan Gong, Pengyang Gu, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 14
Liquid biopsy: paving a new avenue for cancer research
Keerthi Kurma, Zahra Eslami‐S, Catherine Alix‐Panabières, et al.
Cell Adhesion & Migration (2024) Vol. 18, Iss. 1, pp. 1-26
Open Access | Times Cited: 6
Morphologic-Molecular Transformation of Oncogene Addicted Non-Small Cell Lung Cancer
Fiorella Calabrese, Federica Pezzuto, Francesca Lunardi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4164-4164
Open Access | Times Cited: 17
Biologics for novel driver altered non-small cell lung cancer: potential and pitfalls
Gianluca Russo, Claudia Scimone, Lucia Palumbo, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104748-104748
Open Access
Circulating Tumor Cells Enumeration from the Portal Vein for Risk Stratification in Early Pancreatic Cancer Patients
Javier Padillo-Ruíz, G. Suárez, Sheila Pereira, et al.
Cancers (2021) Vol. 13, Iss. 24, pp. 6153-6153
Open Access | Times Cited: 23
Circulating Cell-Free DNA in Renal Cell Carcinoma: The New Era of Precision Medicine
Edoardo Francini, Giuseppe Nicolò Fanelli, Filippo Pederzoli, et al.
Cancers (2022) Vol. 14, Iss. 18, pp. 4359-4359
Open Access | Times Cited: 14
Convergence of Precision Oncology and Liquid Biopsy in Non-Small Cell Lung Cancer
Ebaa Al-Obeidi, Jonathan W. Riess, Umberto Malapelle, et al.
Hematology/Oncology Clinics of North America (2023) Vol. 37, Iss. 3, pp. 475-487
Closed Access | Times Cited: 8
A narrative review of methods for the identification of ALK fusions in patients with non-small cell lung carcinoma
Susana Hernández, Esther Conde, Marta Alonso de la Varga, et al.
Translational Lung Cancer Research (2023) Vol. 12, Iss. 7, pp. 1549-1562
Open Access | Times Cited: 8
Quantification and Characterization of CTCs and Clusters in Pancreatic Cancer by Means of the Hough Transform Algorithm
Francisco José Calero-Castro, Sheila Pereira, Imán Laga, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4278-4278
Open Access | Times Cited: 7
Unveiling diagnostic potential of extracellular DNA and lung tissue-specific X gene expression in non-small cell lung carcinoma patients
Shivani Singh, Vibhav Nigam, Sandeep Kumar, et al.
Human Gene (2024) Vol. 39, pp. 201266-201266
Open Access | Times Cited: 2
Overview of the role of liquid biopsy in non-small cell lung cancer (NSCLC)
Aylen Vanessa Ospina
Clinical Oncology (2024) Vol. 36, Iss. 10, pp. e371-e380
Closed Access | Times Cited: 2
Nanoscale Extracellular Vesicle-Enabled Liquid Biopsy: Advances and Challenges for Lung Cancer Detection
Adeel Khan, Faisal Raza, Nongyue He
Micromachines (2024) Vol. 15, Iss. 10, pp. 1181-1181
Open Access | Times Cited: 2
Dynamic evaluation of blood immune cells predictive of response to immune checkpoint inhibitors in NSCLC by multicolor spectrum flow cytometry
Weijie Ma, Sixi Wei, Siqi Long, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Liquid biopsy for the management of NSCLC patients under osimertinib treatment
Aliki Ntzifa, Theodoros Marras, Vassilis Georgoulias, et al.
Critical Reviews in Clinical Laboratory Sciences (2024) Vol. 61, Iss. 5, pp. 347-369
Closed Access | Times Cited: 1
Improved platelet separation performance from whole blood using an acoustic fluidics system
Kazuko Sakai, Shuta Ohara, Junko Tanaka, et al.
Cancer Science (2024) Vol. 115, Iss. 11, pp. 3795-3803
Open Access | Times Cited: 1
Tracking and tackling the tumor dynamics clonal evolution: osimertinib rechallenge after interval therapy might be an effective treatment approach in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC)
Giulio Metro, Angelo Bonaiti, Ilaria Birocchi, et al.
Journal of Thoracic Disease (2022) Vol. 14, Iss. 4, pp. 816-819
Open Access | Times Cited: 3
Liquid Biopsy in the Oncological Management of a Histologically Undiagnosed Lung Carcinoma: A Case Report
Giovanni Fadda, Renato Lobrano, Milena Casula, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 11, pp. 1874-1874
Open Access | Times Cited: 3
BL-MOL-AR Project, Preliminary Results about Liquid Biopsy: Molecular Approach Experience and Research Activity in Oncological Settings
Alessandro Pancrazzi, Francesco Bloise, Alice Moncada, et al.
Global Medical Genetics (2023) Vol. 10, Iss. 03, pp. 172-187
Open Access | Times Cited: 1
Liquid Biopsy
Valeria Denninghoff, María José Serrano
IntechOpen eBooks (2023)
Open Access | Times Cited: 1
Clinical translational research of liquid biopsy applications in prostate cancer and other urological cancers
Jingyi Huang, Da Huang, Xiaohao Ruan, et al.
Cambridge Prisms Precision Medicine (2023) Vol. 1
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top